Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Alpert

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
Psychosomatic Medicine|October 6, 2005
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorderDan V Iosifescu, Nicoletta Clementi-Craven, Renerio Fraguas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 16, 2004
Psychosocial functioning in patients with treatment resistant depressionTimothy Petersen, George I Papakostas, Yasmin Mahal, et al.
Comprehensive Psychiatry|January 14, 2003
Functioning and interpersonal relationships as predictors of response in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Psychiatry Research|June 12, 2003
Axis III disorders in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Psychosomatics|October 27, 2009
Pattern of depressive symptoms in Parkinson's diseaseAmy H Farabaugh, Joseph J Locascio, Liang Yap, et al.
Psychiatry Research|November 22, 2005
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I)Dan V Iosifescu, George I Papakostas, In Kyoon Lyoo, et al.
The Journal of Clinical Psychiatry|August 10, 2005
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorderDan V Iosifescu, Andrew A Nierenberg, David Mischoulon, et al.
The American Journal of Psychiatry|November 9, 2023
Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care WorkersAaron Samuel Breslow, Sherry Simkovic, Peter J Franz, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorderRoy H Perlis, Andrew A Nierenberg, Jonathan E Alpert, et al.
Psychosomatic Medicine|October 6, 2005
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorderDan V Iosifescu, Nicoletta Clementi-Craven, Renerio Fraguas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 16, 2004
Psychosocial functioning in patients with treatment resistant depressionTimothy Petersen, George I Papakostas, Yasmin Mahal, et al.
Comprehensive Psychiatry|January 14, 2003
Functioning and interpersonal relationships as predictors of response in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Psychiatry Research|June 12, 2003
Axis III disorders in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
Psychosomatics|October 27, 2009
Pattern of depressive symptoms in Parkinson's diseaseAmy H Farabaugh, Joseph J Locascio, Liang Yap, et al.
Psychiatry Research|November 22, 2005
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I)Dan V Iosifescu, George I Papakostas, In Kyoon Lyoo, et al.
The Journal of Clinical Psychiatry|August 10, 2005
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorderDan V Iosifescu, Andrew A Nierenberg, David Mischoulon, et al.
The American Journal of Psychiatry|November 9, 2023
Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care WorkersAaron Samuel Breslow, Sherry Simkovic, Peter J Franz, et al.
Pageof 14